Alliance for Clinical Trials in Oncology’s Post

Matthew Galsky, MD, of Icahn School of Medicine at Mount Sinai, leads Alliance A032103 (MODERN) – a trial that tests the role of DNA released from tumor cells into the blood in guiding the use of immunotherapy (nivolumab alone or with relatlimab) after surgical removal of the bladder for #bladdercancer treatment. To learn more about the Alliance MODERN trial, visit https://lnkd.in/eiyxbSqD #NCI #NCTN

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics